DNA Vaccines: The Next Stage in the Vaccine Revolution?

DNA vaccines

Clinical OMICs: Over the last two years, there has been an unprecedented frenzy to develop new vaccines due to the COVID-19 pandemic, but DNA vaccines have rather stood in the shadow of their mRNA cousins. With the first DNA vaccine against SARS-CoV-2 now approved in India, what’s next in this field and can these vaccines compete with others on the market?

The first human DNA vaccine, developed by Zydus Cadila, received market approval in India in August for protection against COVID-19. Although several veterinary DNA vaccines have been approved, this is the first ever in humans.

So why is there only one COVID-19 DNA vaccine, out of 22 approved in different countries around the world and why in India?

Helen Horton, Chief Research Officer at Touchlight talks to Clinical OMICs about the advantages of DNA vaccines and the future for genetic medicine.

Read more


Learn more about how Touchlight’s doggybone DNA is transforming advanced therapy manufacturing.